跳转至内容
Merck
CN

SML1045

Sigma-Aldrich

Thiazovivin

≥98% (HPLC), powder, Rho Kinase inhibitor

登录查看公司和协议定价

别名:
N-苄基-2-(嘧啶-4-基氨基)噻唑-4-甲酰胺
经验公式(希尔记法):
C15H13N5OS
分子量:
311.36
UNSPSC代码:
12352200
NACRES:
NA.77

质量水平

检测方案

≥98% (HPLC)

形式

powder

颜色

, white to beige to brown

溶解性

DMSO: 20 mg/mL, clear

储存温度

−20°C

InChI

1S/C15H13N5OS/c21-14(17-8-11-4-2-1-3-5-11)12-9-22-15(19-12)20-13-6-7-16-10-18-13/h1-7,9-10H,8H2,(H,17,21)(H,16,18,19,20)

InChI key

DOBKQCZBPPCLEG-UHFFFAOYSA-N

应用

Thiazovivin 已被用于从人尿液细胞生成诱导多能干细胞 (iPSC) 和诱导神经干细胞 (iNSC)。也用于研究促纤维化抑制对心脏重编程的影响。

生化/生理作用

Thiazovivin 是一种 Rho 激酶 (ROCK) 抑制剂,与 ALK5 抑制剂 SB-431542 (S4317) 和 MEK 抑制剂 PD-0325901 (PZ0162) 联合使用时,促进成纤维细胞向干细胞转化的效率比经典方法高 200 倍。Thiazovivin 可稳定细胞表面的上皮细胞钙粘蛋白,这是培养中人类胚胎干细胞生存所必需的。当人类胚胎干细胞从集落中剪出时,这种关键蛋白被破坏,然后在细胞内内化。细胞表面没有上皮细胞钙粘蛋白,细胞与其环境之间的细胞信号被破坏,细胞很快死亡。
Thiazovivin 是一种 Rho 相关的含卷曲螺旋的蛋白激酶 (ROCK) 抑制剂。体外研究证明,Thiazovivin 可有效刺激更好的形态、离子转运蛋白和细胞粘附相关蛋白的表达。

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Daniel A Armendariz et al.
eLife, 12 (2023-04-25)
Enhancers orchestrate gene expression programs that drive multicellular development and lineage commitment. Thus, genetic variants at enhancers are thought to contribute to developmental diseases by altering cell fate commitment. However, while many variant-containing enhancers have been identified, studies to endogenously
The ROCK inhibitor, thiazovivin, inhibits human corneal endothelial-to-mesenchymal transition/epithelial-to-mesenchymal transition and increases ionic transporter expression.
Wu Q, et al.
International Journal of Molecular Medicine, 40(4), 1009-1018 (2017)
Generation of Urine Cell-Derived Non-integrative Human iPSCs and iNSCs: A Step-by-Step Optimized Protocol.
Cheng L, et al.
Frontiers in Molecular Neuroscience, 10, 348-348 (2017)
Yonatan R Lewis-Israeli et al.
Journal of visualized experiments : JoVE, (175) (2021-10-05)
The ability to study human cardiac development in health and disease is highly limited by the capacity to model the complexity of the human heart in vitro. Developing more efficient organ-like platforms that can model complex in vivo phenotypes, such
Imen Jebeniani et al.
Methods in molecular biology (Clifton, N.J.), 1994, 71-77 (2019-05-28)
Pluripotent stem cells feature the capacity to differentiate into any somatic cell types including cardiomyocytes. We report a cost-effective and simple protocol for the differentiation of specific ventricular cardiomyocytes. These cells are elongated, do not spontaneously beat, and do not

商品

Naive pluripotent stem cells cultured in vitro using specialized media and inhibitors mimic "ground-state" cells from blastocysts.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门